Filing Summary
Company: Suja Life, Inc. (Nasdaq: SUJA). Filing: Form 8-K reporting an event dated October 16, 2026; the related press release was issued October 20, 2026.
Business Context and Reporting Period
The filing concerns board appointments and governance, not a financial reporting period. Suja Life increased its board from seven to nine members and appointed Robert B. Engel and Zahir Ibrahim, effective immediately. Both appointments were designated by certain affiliates of Paine Schwartz Partners under a Director Designation Agreement dated May 8, 2026.
Financial Information
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating performance metrics. It reports director compensation: each appointee will receive an annual cash retainer of $75,000 and restricted stock units with an annual grant-date fair value of $100,000, prorated for time served.
Appointments and Other Disclosures
- Engel will serve as a Class I director until the 2027 annual meeting and was appointed to the Audit Committee. His background includes senior banking roles, public accounting, and board service.
- Ibrahim will serve as a Class II director until the 2028 annual meeting. He has held CFO and finance leadership roles at BARK, Do Good Foods, KIND, Annie’s, and Molson Coors.
- The company stated that no transactions involving either appointee require disclosure under Item 404(a) of Regulation S-K.
- The company entered into indemnification agreements with both directors in a form consistent with its agreements with other directors.
Outlook, Risks, and Unusual Items
No financial guidance, business outlook, contingencies, or material operating risks are discussed. The principal reported change is the expansion of the board and appointment of two directors designated under the Director Designation Agreement.
Key Facts for Investors to Verify
- Confirm the appointments, board class terms, and Engel’s Audit Committee role.
- Review the Director Designation Agreement and any related governance disclosures for the Principal Stockholder’s rights.
- Assess the compensation policy and the prorated restricted-stock-unit awards in the company’s subsequent filings.
- Consult future periodic reports for financial results; this 8-K contains no financial performance update.